ETI
HALO icon

Enterprise Trust & Investment’s Halozyme HALO Stock Holding History

Enterprise Trust & Investment’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2K Buy
+56
New +$2.42K ﹤0.01% 344

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Enterprise Trust & Investment's HALO Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in Halozyme (HALO) in Q2 2022: 56 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #344 among its holdings.

367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Enterprise Trust & Investment held 56 shares of Halozyme worth $2K as of Q2 2022.
  • Halozyme was a new Enterprise Trust & Investment position in Q2 2022.
  • Halozyme made up ﹤0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #344 holding.
  • 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.